Page last updated: 2024-10-19

niacinamide and Mole, Skin

niacinamide has been researched along with Mole, Skin in 2 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Research Excerpts

ExcerptRelevanceReference
"Sorafenib is a new multikinase inhibitor recently approved for renal cell carcinoma and hepatocarcinoma."1.35[Eruptive nevi associated with sorafenib treatment]. ( Bennani-Lahlou, M; Escudier, B; Massard, C; Mateus, C; Robert, C; Soria, JC; Spatz, A, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennani-Lahlou, M1
Mateus, C1
Escudier, B1
Massard, C1
Soria, JC1
Spatz, A1
Robert, C1
Jilaveanu, LB1
Zito, CR1
Aziz, SA1
Conrad, PJ1
Schmitz, JC1
Sznol, M1
Camp, RL1
Rimm, DL1
Kluger, HM1

Other Studies

2 other studies available for niacinamide and Mole, Skin

ArticleYear
[Eruptive nevi associated with sorafenib treatment].
    Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Benzenesulfonates; Humans; Male; Middle Aged; Nevus; Niacinamide

2008
C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Sep-15, Volume: 15, Issue:18

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzenesulfonates; Cell Line, Tumor; Cell Proliferation;

2009